Zobrazeno 1 - 10
of 30
pro vyhledávání: '"63"'
Autor:
Manuel A. Amaris, Kulwinder S. Dua, Reza Shaker, Muhammad Hafeezullah, Shiko Kuribayashi, Sri Naveen Surapaneni
Publikováno v:
Gastroenterology. 138:S-13
Introduction: Although achalasia is the best defined esophageal motor disorder, no standardized patient reported outcome measure currently exists for intervention trials. Furthermore, treatment outcome from a patients perspective can be quite differe
Autor:
Rifat Hamoudi, A Ruskone-Fourmestraux, Thomas Wündisch, Pier Luigi Zinzani, Ahmet Dogan, Andreas Neubauer, Anne Lavergne, Ming-Qing Du, Christian Thiede, Peter G. Isaacson, Giancarlo Caletti, Daphne de Jong, Togliani Thomas, Hongtao Ye, Babs G. Taal, Thierry Jo Molina, Manfred Stolte, Hongxiang Liu, Sabattini Elena, Stefano Pileri, Henk Boot
Publikováno v:
Gastroenterology. 122:1286-1294
Background & Aims: Eradication of Helicobacter pylori leads to cure of gastric mucosa-associated lymphoid tissue (MALT) lymphoma in 75% of localized cases. However, prolonged follow-up is necessary to determine whether a lymphoma responds to therapy.
Autor:
Catherine Gestrich, Shahrazad Saab, Erin Crawford, Jonathan Moses, Sindhoosha Malay, Thomas J. Sferra
Publikováno v:
Gastroenterology. 158:S27
Background Inflammatory bowel disease (IBD) treatment strategies have evolved to target mucosal healing, which has been shown to be associated with clinical remission and reduced complications. Fecal calprotectin (FC) is a non-invasive marker of inte
Autor:
Isabelle Doukhan, Albert Vuagnat, Philippe Ruszniewski, Michel Mignon, Guillaume Cadiot, Albert Beckers, Brigitte Delemer, Charles Proye, Arnaud Murat, Gérard Thiéfin, Michel Veyrac, Guillaume Bonnaud
Publikováno v:
Gastroenterology. 116:286-293
Background & Aims: Risk factors of metachronous liver metastases and death are not well known in patients with the Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1. These factors were retrospectively determined in 77 patients. Met
Autor:
Barbara S. Kirschner, Barry H. Rich, Ranjana Gokhale, Theodore Karrison, Marjorie M. Sutton, Murray J. Favus
Publikováno v:
Gastroenterology. 114:902-911
Background & Aims: Children with inflammatory bowel disease (IBD) are at risk for osteoporosis because of undernutrition, delayed puberty, and prolonged corticosteroid use. The aim of this study was to compare bone mineral density (BMD) in children w
Autor:
John R. Goldblum, Joel E. Richter, Thomas W. Rice, Gary W. Falk, Ravi Chittajallu, Robert E. Petras, Kim R. Geisinger, Sigurbjorn Birgisson, Charles V. Biscotti
Publikováno v:
Gastroenterology. 112:1787-1797
BACKGROUND & AIMS: A less costly cancer surveillance method for Barrett's esophagus is desirable. The aim of this study was to compare nonendoscopic balloon cytology with biopsy and brush cytology for detecting dysplasia and carcinoma in patients wit
Autor:
Markus Büchler, Peter Malfertheiner, O. Pieramico, J. Enrique Dominguez-Muñoz, Daniel K. Nelson, Wolfgang Böck
Publikováno v:
Gastroenterology. 109:224-230
Background & Aims: Secretions from the exocrine and endocrine pancreas may modulate interdigestive motility. To test this hypothesis in humans, we investigated interdigestive cycling in patients with chronic pancreatitis (CP) as a model of impaired p
Autor:
Clifford T. Lomboy, Alan J. Cameron
Publikováno v:
Gastroenterology. 103:1241-1245
The development of Barrett's esophagus was studied using data from 51,311 patients undergoing upper gastrointestinal endoscopy between 1976 and 1989. Three hundred seventy-seven patients had greater than or equal to 3-cm columnar epithelium in the es
Publikováno v:
Gastroenterology. 102:931-935
Sodium retention and peripheral vasodilatation are common consequences of portal hypertension secondary to cirrhosis. Although peripheral vasodilatation has been extensively documented in prehepatic portal hypertension, it is not known whether sodium
Publikováno v:
Gastroenterology. 127(5 Suppl 1)
This phase II trial was undertaken to determine the efficacy and toxicity of proton beam radiotherapy for patients with locally unresectable hepatocellular carcinoma. Cirrhotic patients were eligible if they had a Child-Pugh score of 10 or less. Elig